Clinical management of metastatic hormone receptor-positive, HER2-negative breast cancer (MBC) after CDK 4/6 inhibitors: a retrospective single-institution study
Titel:
Clinical management of metastatic hormone receptor-positive, HER2-negative breast cancer (MBC) after CDK 4/6 inhibitors: a retrospective single-institution study
Auteur:
Choong, Grace M. Liddell, Savannah Ferre, Roberto A. Leon O’Sullivan, Ciara C. Ruddy, Kathryn J. Haddad, Tufia C. Hobday, Timothy J. Peethambaram, Prema P. Liu, Minetta C. Goetz, Matthew P. Giridhar, Karthik V.